Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
29,909 total articles
Barclays trimmed its 12-month price target for Oracle to $230 from $310 and signaled that the company’s accelerating AI-related revenue growth could bring near-term margin pressure. Analyst Raimo Lenschow expects a noticeable AI-driven revenue acceleration in Oracle’s fiscal third quarter, but he warns that investments and lease-expense timing tied…
BofA Securities, following discussions with telecom equipment vendors at Mobile World Congress 2026, identified expanding demand in optical networking and mission-critical 5G upgrades but kept a guarded view on short-term sector growth. The broker lifted its price objective on Nokia, citing AI-enabled RAN progress and a backlog skewed to optical an…
BofA Securities upgraded Temenos AG from neutral to buy and lifted its price target to CHF96 from CHF92, arguing that shares trade meaningfully below historical valuations despite recent revenue growth and guidance that outpaces consensus. The bank highlights low AI substitution risk in core banking, projects higher-than-consensus earnings and cash…
Saudi Arabia's main stock index, the Tadawul All Share, finished Monday down 1.60% as losses in Transport, Hotels & Tourism and Media & Publishing weighed on the market. While several individual stocks recorded strong gains, a larger number of declines pushed the exchange lower. Crude oil prices rose sharply, while gold futures and currency pairs s…
Jefferies analysts contend that artificial intelligence is unlikely to disintermediate commercial property and casualty (P&C) brokers outside of the smallest commercial segments. The firm argues that complexity, advisory services, and data limitations shield upper middle market, large, specialty, and reinsurance brokerages, and views AI primarily a…
Founder Group's shares climbed 20% after the company announced an approximately RM16 million (US$4.14 million) Engineering, Procurement, Construction, and Commissioning contract to build a 25.40MW solar photovoltaic facility in Malaysia under the government-backed Corporate Green Power Programme. The project is expected to produce roughly 53,000 MW…
Jefferies analysts report that energy drink availability across U.S. grocery and convenience channels has grown markedly over the past three years, even as the category's share of total non-alcoholic beverage distribution points has edged up only slightly. The firm continues to hold Buy ratings on Monster Beverage (MNST) and Celsius Holdings (CELH)…
Citi warns rising memory prices will pressure Apple’s profitability in calendar 2026, estimating a 140 basis-point gross margin hit and a further 48 basis points in 2027 tied to sharp DRAM price increases. The bank trimmed fiscal 2026 and 2027 earnings per share modestly while leaving its 2028 forecast intact and kept its Buy rating and $315 price …
Morgan Stanley attributes a recent deceleration in Mounjaro sales in Brazil to supply constraints rather than weaker demand. Retailers consistently reported limited inventory even as patient interest remained strong. Weak U.S. GLP-1 imports in December and January may have constrained available product, with a sharp rebound in February imports offe…
Shares of Syntec Optics (NASDAQ:OPTX) climbed 18% after the company announced defense purchase orders exceeding $4 million for optics and opto-mechanical assemblies across multiple U.S. military platforms. The orders cover laser guidance for precision missiles, surveillance and targeting systems, night-vision equipment, specialized defense lasers, …
Shares of Olema Pharmaceuticals (NASDAQ:OLMA) tumbled 41% on Monday after Roche disclosed that its Phase 3 persevERA study failed to achieve a statistically significant improvement in progression-free survival for giredestrant plus palbociclib versus an aromatase inhibitor plus palbociclib. Roche said a numerical improvement was observed but it did…
Macquarie removed MakeMyTrip (NASDAQ:MMYT) from its Asia Marquee list after the stock fell 25% since being added on December 8, 2025. The broker highlighted an approximately 80% surge in jet fuel spot prices versus the December-quarter average and said geopolitical dynamics are pressuring international travel flows, which weigh on the company’s hig…
Canada's main index futures fell on Monday as intensifying hostilities in the Middle East pushed crude prices sharply higher and unsettled investors. Commodities-heavy S&P/TSX 60 futures lost ground by early trade, while U.S. equity futures plunged as oil surged above $100 a barrel and worries grew that a renewed energy shock could stoke inflation …
Bank of America says a recent hardening in Iran's leadership and the effective closure of the Strait of Hormuz have driven a swift tightening in oil and LNG supplies, lifting front-month Brent above $105 per barrel and TTF gas above e260 per megawatt-hour. The bank reports operational suspensions across several Gulf producers and expects roughly 30…
Bank of America on Monday flagged several optical networking companies as likely beneficiaries of sustained demand from data centers combined with tight supply dynamics. The bank identified firms with technical strengths in key components and materials as positioned to capture share amid an industry shift from 800G to 1.6T technology and extended c…
Oracle has publicly rejected recent reports that expansion plans at its Abilene, Texas AI data center were abandoned or troubled, stating that the campus remains on schedule, two buildings are fully operational, and the company has secured the full 4.5 gigawatts of additional capacity it pledged to OpenAI. The clarification arrives amid mixed marke…
Morgan Stanley assesses that Brunello Cucinelli's U.S. revenue will only be modestly affected by additional Saks Global store closures announced March 6, noting the Italian luxury house has limited exposure concentrated in a handful of Saks Fifth Avenue and Neiman Marcus locations and benefits from clienteling and brand loyalty that should help dis…
XPeng (NYSE:XPEV) stock rose after Morgan Stanley analysts reported favorable impressions from a hands-on 28-kilometer test of the automaker's VLA 2.0 autonomous driving system in Guangzhou. The brokerage highlighted smoother, more human-like control and said the immediate challenge is converting improved AD tech into broader consumer adoption and …
uniQure shares climbed 36% after reports that Vinay Prasad, head of the FDA’s division of vaccines and gene therapies, will leave the agency next month to return to academia. The move triggered analyst upgrades for uniQure and broader rallies among gene therapy and rare disease stocks, with REGENXBIO up 13% and Biohaven rising 23%. Several analysts…
Indonesia's Communications and Digital Ministry has distributed a ministerial regulation that directs platforms to deactivate social media accounts deemed 'high risk' for users under 16, effective March 28. Platforms named by the ministry include Roblox, Instagram, YouTube and TikTok. Company spokespeople said they are reviewing the rule and engagi…
Xenon Pharmaceuticals shares climbed 40% after topline results from the Phase 3 X-TOLE2 trial showed azetukalner significantly reduced focal onset seizure frequency versus placebo, meeting both primary and key secondary endpoints in two dose groups. The company plans to submit a New Drug Application in the third quarter of 2026.
U.S. stock futures fell sharply Monday after escalation in the Middle East conflict pushed energy prices higher, stoking worries about future economic growth. In premarket action a range of companies moved decisively: Hims & Hers and several smaller biotech and specialty companies jumped, while established drugmakers and life-science suppliers dipp…
Korro Bio Inc. (NASDAQ:KRRO) said on Monday it has secured an oversubscribed $85 million private investment in public equity (PIPE) financing, led by Venrock Healthcare Capital Partners. The financing, which prompted a 17% intraday gain for KRRO shares, will combine with the company's existing cash and marketable securities to extend its cash runwa…
Shares of Precision BioSciences (NASDAQ:DTIL) rose after the U.S. Food and Drug Administration awarded Fast Track status to PBGENE-DMD, the company's in vivo gene editing candidate for Duchenne muscular dystrophy. The designation is intended to streamline development and review, and follows IND clearance and plans for a Phase 1/2 study named FUNCTI…
U.S. stock indexes finished the week lower as a steep rise in oil prices and weaker-than-expected February jobs data weighed on sentiment. The Dow dropped about 0.95%, the S&P 500 fell 1.33% and the Nasdaq declined 1.59% on Friday. WTI crude climbed above $90 a barrel and registered roughly a 35% weekly gain - its largest since futures began tradin…
